BBIO · BridgeBio Pharma, Inc. · Debt
Market Cap
$14.72B
Shares
195.49M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1743881
CUSIP
10806X102
13F (30d)
257 filings
253 filers
Visit website
Investor relations